NCT05561842View on ClinicalTrials.gov

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

RecruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

September 21, 2026

Study Completion Date

September 21, 2027

Conditions
Breast CancerBreast Cancer Female
Interventions
PROCEDURE

mHealth US-breast biopsy

During this study, women will undergo an US-guided breast biopsy by a radiologist instead of what is typically performed in Nigerian hospitals, which is either a blind biopsy or surgical excision. US-guided breast biopsy is the standard of care in the United States of America because the accuracy is better than blind biopsy and equal to surgical excision.

Trial Locations (8)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Unknown

RECRUITING

Lagos University Teaching Hospital, Idi-Araba

ACTIVE_NOT_RECRUITING

Olabisis Onabanjo University Teaching Hospital (Data Collection Only), Sagamu

RECRUITING

Federal Medical Centre Owo (Data Collection Only), Owo

ACTIVE_NOT_RECRUITING

University College Hospital (Data Collection Only), Ibadan

RECRUITING

University Of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla Enugu, Enugu

RECRUITING

Obafemi Awolowo University Teaching Hospitals Complex (Data Collection Only), Ile-Ife

ACTIVE_NOT_RECRUITING

University of Ilorin Teaching Hospitals, Ilorin

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER